Your browser doesn't support javascript.
loading
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.
Kulkarni, Prasad S; Hurwitz, Julia L; Simões, Eric A F; Piedra, Pedro A.
Affiliation
  • Kulkarni PS; 1 Serum Institute of India Pvt Ltd , Pune, India .
  • Hurwitz JL; 2 Department of Infectious Diseases, St. Jude Children's Research Hospital , Memphis, Tennessee.
  • Simões EAF; 3 Department of Microbiology, Immunology, and Biochemistry, The University of Tennessee Health Science Center , Memphis, Tennessee.
  • Piedra PA; 4 Department of Pediatrics, University of Colorado School of Medicine , Aurora, Colorado.
Viral Immunol ; 31(2): 195-203, 2018 03.
Article in En | MEDLINE | ID: mdl-29336703
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers / Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines / Drug Evaluation, Preclinical / Drug Discovery Type of study: Clinical_trials Limits: Humans Language: En Journal: Viral Immunol Journal subject: ALERGIA E IMUNOLOGIA / VIROLOGIA Year: 2018 Type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers / Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines / Drug Evaluation, Preclinical / Drug Discovery Type of study: Clinical_trials Limits: Humans Language: En Journal: Viral Immunol Journal subject: ALERGIA E IMUNOLOGIA / VIROLOGIA Year: 2018 Type: Article Affiliation country: India